6-(5-methoxy-3-pyridinyl)-N-[4-(4-methylsulfonylpiperazin-1-yl)cyclohexyl]-9H-pyrido[2,3-b]indol-4-amine;6-(5-methoxy-3-pyridinyl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(1-methylpyrazol-4-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(5-methyl-1H-1,2,4-triazol-3-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrimido[4,5-b]indol-4-amine;N-(4-morpholin-4-ylcyclohexyl)-6-(1H-1,2,4-triazol-5-yl)-9H-pyrimido[4,5-b]indol-4-amine

C125H149N33O8S — CID 163459145

IUPAC6-(5-methoxy-3-pyridinyl)-N-[4-(4-methylsulfonylpiperazin-1-yl)cyclohexyl]-9H-pyrido[2,3-b]indol-4-amine;6-(5-methoxy-3-pyridinyl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(1-methylpyrazol-4-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(5-methyl-1H-1,2,4-triazol-3-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrimido[4,5-b]indol-4-amine;N-(4-morpholin-4-ylcyclohexyl)-6-(1H-1,2,4-triazol-5-yl)-9H-pyrimido[4,5-b]indol-4-amine
SMILESCOc1cncc(-c2ccc3[nH]c4nccc(NC5CCC(N6CCN(S(C)(=O)=O)CC6)CC5)c4c3c2)c1.COc1cncc(-c2ccc3[nH]c4nccc(NC5CCC(N6CCOCC6)CC5)c4c3c2)c1.Cc1nc(-c2ccc3[nH]c4ncnc(NC5CCC(N6CCOCC6)CC5)c4c3c2)n[nH]1.Cn1cc(-c2ccc3[nH]c4nccc(NC5CCC(N6CCOCC6)CC5)c4c3c2)cn1.c1n[nH]c(-c2ccc3[nH]c4ncnc(NC5CCC(N6CCOCC6)CC5)c4c3c2)n1
InChIInChI=1S/C28H34N6O3S.C27H31N5O2.C25H30N6O.C23H28N8O.C22H26N8O/c1-37-23-15-20(17-29-18-23)19-3-8-25-24(16-19)27-26(9-10-30-28(27)32-25)31-21-4-6-22(7-5-21)33-11-13-34(14-12-33)38(2,35)36;1-33-22-14-19(16-28-17-22)18-2-7-24-23(15-18)26-25(8-9-29-27(26)31-24)30-20-3-5-21(6-4-20)32-10-12-34-13-11-32;1-30-16-18(15-27-30)17-2-7-22-21(14-17)24-23(8-9-26-25(24)29-22)28-19-3-5-20(6-4-19)31-10-12-32-13-11-31;1-14-26-21(30-29-14)15-2-7-19-18(12-15)20-22(24-13-25-23(20)28-19)27-16-3-5-17(6-4-16)31-8-10-32-11-9-31;1-6-18-17(11-14(1)20-25-13-26-29-20)19-21(23-12-24-22(19)28-18)27-15-2-4-16(5-3-15)30-7-9-31-10-8-30/h3,8-10,15-18,21-22H,4-7,11-14H2,1-2H3,(H2,30,31,32);2,7-9,14-17,20-21H,3-6,10-13H2,1H3,(H2,29,30,31);2,7-9,14-16,19-20H,3-6,10-13H2,1H3,(H2,26,28,29);2,7,12-13,16-17H,3-6,8-11H2,1H3,(H,26,29,30)(H2,24,25,27,28);1,6,11-13,15-16H,2-5,7-10H2,(H,25,26,29)(H2,23,24,27,28)
InChIKeyBNBPNJRXSRYBKQ-UHFFFAOYSA-N
MW2273.86 g/mol
LogP19.31
Rot. Bonds23

About 6-(5-methoxy-3-pyridinyl)-N-[4-(4-methylsulfonylpiperazin-1-yl)cyclohexyl]-9H-pyrido[2,3-b]indol-4-amine;6-(5-methoxy-3-pyridinyl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(1-methylpyrazol-4-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(5-methyl-1H-1,2,4-triazol-3-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrimido[4,5-b]indol-4-amine;N-(4-morpholin-4-ylcyclohexyl)-6-(1H-1,2,4-triazol-5-yl)-9H-pyrimido[4,5-b]indol-4-amine

6-(5-methoxy-3-pyridinyl)-N-[4-(4-methylsulfonylpiperazin-1-yl)cyclohexyl]-9H-pyrido[2,3-b]indol-4-amine;6-(5-methoxy-3-pyridinyl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(1-methylpyrazol-4-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(5-methyl-1H-1,2,4-triazol-3-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrimido[4,5-b]indol-4-amine;N-(4-morpholin-4-ylcyclohexyl)-6-(1H-1,2,4-triazol-5-yl)-9H-pyrimido[4,5-b]indol-4-amine (PubChem CID 163459145) has the molecular formula C125H149N33O8S and a molecular weight of 2273.86 g/mol. Its IUPAC name is 6-(5-methoxy-3-pyridinyl)-N-[4-(4-methylsulfonylpiperazin-1-yl)cyclohexyl]-9H-pyrido[2,3-b]indol-4-amine;6-(5-methoxy-3-pyridinyl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(1-methylpyrazol-4-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(5-methyl-1H-1,2,4-triazol-3-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrimido[4,5-b]indol-4-amine;N-(4-morpholin-4-ylcyclohexyl)-6-(1H-1,2,4-triazol-5-yl)-9H-pyrimido[4,5-b]indol-4-amine.

Molecular Properties

Compound Name6-(5-methoxy-3-pyridinyl)-N-[4-(4-methylsulfonylpiperazin-1-yl)cyclohexyl]-9H-pyrido[2,3-b]indol-4-amine;6-(5-methoxy-3-pyridinyl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(1-methylpyrazol-4-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(5-methyl-1H-1,2,4-triazol-3-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrimido[4,5-b]indol-4-amine;N-(4-morpholin-4-ylcyclohexyl)-6-(1H-1,2,4-triazol-5-yl)-9H-pyrimido[4,5-b]indol-4-amine
PubChem CID163459145
Molecular FormulaC125H149N33O8S
Molecular Weight2273.86 g/mol
Exact Mass2272.20
IUPAC Name6-(5-methoxy-3-pyridinyl)-N-[4-(4-methylsulfonylpiperazin-1-yl)cyclohexyl]-9H-pyrido[2,3-b]indol-4-amine;6-(5-methoxy-3-pyridinyl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(1-methylpyrazol-4-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(5-methyl-1H-1,2,4-triazol-3-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrimido[4,5-b]indol-4-amine;N-(4-morpholin-4-ylcyclohexyl)-6-(1H-1,2,4-triazol-5-yl)-9H-pyrimido[4,5-b]indol-4-amine
SMILESCOc1cncc(-c2ccc3[nH]c4nccc(NC5CCC(N6CCN(S(C)(=O)=O)CC6)CC5)c4c3c2)c1.COc1cncc(-c2ccc3[nH]c4nccc(NC5CCC(N6CCOCC6)CC5)c4c3c2)c1.Cc1nc(-c2ccc3[nH]c4ncnc(NC5CCC(N6CCOCC6)CC5)c4c3c2)n[nH]1.Cn1cc(-c2ccc3[nH]c4nccc(NC5CCC(N6CCOCC6)CC5)c4c3c2)cn1.c1n[nH]c(-c2ccc3[nH]c4ncnc(NC5CCC(N6CCOCC6)CC5)c4c3c2)n1
InChIInChI=1S/C28H34N6O3S.C27H31N5O2.C25H30N6O.C23H28N8O.C22H26N8O/c1-37-23-15-20(17-29-18-23)19-3-8-25-24(16-19)27-26(9-10-30-28(27)32-25)31-21-4-6-22(7-5-21)33-11-13-34(14-12-33)38(2,35)36;1-33-22-14-19(16-28-17-22)18-2-7-24-23(15-18)26-25(8-9-29-27(26)31-24)30-20-3-5-21(6-4-20)32-10-12-34-13-11-32;1-30-16-18(15-27-30)17-2-7-22-21(14-17)24-23(8-9-26-25(24)29-22)28-19-3-5-20(6-4-19)31-10-12-32-13-11-31;1-14-26-21(30-29-14)15-2-7-19-18(12-15)20-22(24-13-25-23(20)28-19)27-16-3-5-17(6-4-16)31-8-10-32-11-9-31;1-6-18-17(11-14(1)20-25-13-26-29-20)19-21(23-12-24-22(19)28-18)27-15-2-4-16(5-3-15)30-7-9-31-10-8-30/h3,8-10,15-18,21-22H,4-7,11-14H2,1-2H3,(H2,30,31,32);2,7-9,14-17,20-21H,3-6,10-13H2,1H3,(H2,29,30,31);2,7-9,14-16,19-20H,3-6,10-13H2,1H3,(H2,26,28,29);2,7,12-13,16-17H,3-6,8-11H2,1H3,(H,26,29,30)(H2,24,25,27,28);1,6,11-13,15-16H,2-5,7-10H2,(H,25,26,29)(H2,23,24,27,28)
InChIKeyBNBPNJRXSRYBKQ-UHFFFAOYSA-N
XLogP19.31
TPSA465.03 Ų
H-Bond Donors12
H-Bond Acceptors33
Rotatable Bonds23
Heavy Atoms167
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002273.86
LogP ≤ 519.31
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1033

Analyze 6-(5-methoxy-3-pyridinyl)-N-[4-(4-methylsulfonylpiperazin-1-yl)cyclohexyl]-9H-pyrido[2,3-b]indol-4-amine;6-(5-methoxy-3-pyridinyl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(1-methylpyrazol-4-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(5-methyl-1H-1,2,4-triazol-3-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrimido[4,5-b]indol-4-amine;N-(4-morpholin-4-ylcyclohexyl)-6-(1H-1,2,4-triazol-5-yl)-9H-pyrimido[4,5-b]indol-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[[3-fluoro-5-[2-[5-(5-phenylmethoxy-3-pyridinyl)-2H-pyrazolo[3,4-b]pyridin-3-yl]-1H-pyrrolo[3,2-c]pyridin-4-yl]phenyl]methyl]methanesulfonamide
CID 137145078
US10071079, Example 565
CID 135376047
N-[[3-[2-[5-(5-cyclohexyloxy-3-pyridinyl)-1H-indazol-3-yl]-1H-imidazo[4,5-c]pyridin-4-yl]-5-fluorophenyl]methyl]methanesulfonamide
CID 136937004
N-[[3-fluoro-5-[2-[5-(5-piperidin-4-yloxy-3-pyridinyl)-1H-indazol-3-yl]-1H-imidazo[4,5-c]pyridin-4-yl]phenyl]methyl]methanesulfonamide
CID 136937006
N-[[3-fluoro-5-[2-[5-[5-(2-pyrrolidin-1-ylethoxy)-3-pyridinyl]-1H-indazol-3-yl]-1H-imidazo[4,5-c]pyridin-4-yl]phenyl]methyl]methanesulfonamide
CID 136937007
N-[[3-fluoro-5-[2-[5-(5-methoxy-3-pyridinyl)-1H-indazol-3-yl]-1H-imidazo[4,5-c]pyridin-4-yl]phenyl]methyl]methanesulfonamide
CID 136937009
N-[[3-fluoro-5-[2-[5-(5-phenylmethoxy-3-pyridinyl)-1H-indazol-3-yl]-1H-imidazo[4,5-c]pyridin-4-yl]phenyl]methyl]methanesulfonamide
CID 136937011
N-[[3-[2-[5-[5-[2-(dimethylamino)ethoxy]-3-pyridinyl]-1H-indazol-3-yl]-1H-imidazo[4,5-c]pyridin-4-yl]-5-fluorophenyl]methyl]methanesulfonamide
CID 136937012
N-[[3-fluoro-5-[2-[5-(5-piperidin-4-yloxy-3-pyridinyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]-1H-imidazo[4,5-b]pyridin-7-yl]phenyl]methyl]methanesulfonamide
CID 136937331
N-[[3-fluoro-5-[2-[5-[5-(2-pyrrolidin-1-ylethoxy)-3-pyridinyl]-1H-pyrazolo[3,4-c]pyridin-3-yl]-1H-imidazo[4,5-b]pyridin-7-yl]phenyl]methyl]methanesulfonamide
CID 136937346
N-[[3-fluoro-5-[2-[5-(5-methoxy-3-pyridinyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]-1H-imidazo[4,5-b]pyridin-7-yl]phenyl]methyl]methanesulfonamide
CID 136937383
N-[[3-[2-[5-(5-cyclohexyloxy-3-pyridinyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-5-fluorophenyl]methyl]methanesulfonamide
CID 136937486

Frequently Asked Questions

What is the IUPAC name of 6-(5-methoxy-3-pyridinyl)-N-[4-(4-methylsulfonylpiperazin-1-yl)cyclohexyl]-9H-pyrido[2,3-b]indol-4-amine;6-(5-methoxy-3-pyridinyl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(1-methylpyrazol-4-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(5-methyl-1H-1,2,4-triazol-3-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrimido[4,5-b]indol-4-amine;N-(4-morpholin-4-ylcyclohexyl)-6-(1H-1,2,4-triazol-5-yl)-9H-pyrimido[4,5-b]indol-4-amine?
The IUPAC name of 6-(5-methoxy-3-pyridinyl)-N-[4-(4-methylsulfonylpiperazin-1-yl)cyclohexyl]-9H-pyrido[2,3-b]indol-4-amine;6-(5-methoxy-3-pyridinyl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(1-methylpyrazol-4-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(5-methyl-1H-1,2,4-triazol-3-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrimido[4,5-b]indol-4-amine;N-(4-morpholin-4-ylcyclohexyl)-6-(1H-1,2,4-triazol-5-yl)-9H-pyrimido[4,5-b]indol-4-amine (CID 163459145) is 6-(5-methoxy-3-pyridinyl)-N-[4-(4-methylsulfonylpiperazin-1-yl)cyclohexyl]-9H-pyrido[2,3-b]indol-4-amine;6-(5-methoxy-3-pyridinyl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(1-methylpyrazol-4-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(5-methyl-1H-1,2,4-triazol-3-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrimido[4,5-b]indol-4-amine;N-(4-morpholin-4-ylcyclohexyl)-6-(1H-1,2,4-triazol-5-yl)-9H-pyrimido[4,5-b]indol-4-amine.
What is the SMILES notation for 6-(5-methoxy-3-pyridinyl)-N-[4-(4-methylsulfonylpiperazin-1-yl)cyclohexyl]-9H-pyrido[2,3-b]indol-4-amine;6-(5-methoxy-3-pyridinyl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(1-methylpyrazol-4-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(5-methyl-1H-1,2,4-triazol-3-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrimido[4,5-b]indol-4-amine;N-(4-morpholin-4-ylcyclohexyl)-6-(1H-1,2,4-triazol-5-yl)-9H-pyrimido[4,5-b]indol-4-amine?
The canonical SMILES for 6-(5-methoxy-3-pyridinyl)-N-[4-(4-methylsulfonylpiperazin-1-yl)cyclohexyl]-9H-pyrido[2,3-b]indol-4-amine;6-(5-methoxy-3-pyridinyl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(1-methylpyrazol-4-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(5-methyl-1H-1,2,4-triazol-3-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrimido[4,5-b]indol-4-amine;N-(4-morpholin-4-ylcyclohexyl)-6-(1H-1,2,4-triazol-5-yl)-9H-pyrimido[4,5-b]indol-4-amine is COc1cncc(-c2ccc3[nH]c4nccc(NC5CCC(N6CCN(S(C)(=O)=O)CC6)CC5)c4c3c2)c1.COc1cncc(-c2ccc3[nH]c4nccc(NC5CCC(N6CCOCC6)CC5)c4c3c2)c1.Cc1nc(-c2ccc3[nH]c4ncnc(NC5CCC(N6CCOCC6)CC5)c4c3c2)n[nH]1.Cn1cc(-c2ccc3[nH]c4nccc(NC5CCC(N6CCOCC6)CC5)c4c3c2)cn1.c1n[nH]c(-c2ccc3[nH]c4ncnc(NC5CCC(N6CCOCC6)CC5)c4c3c2)n1.
What is the InChIKey of 6-(5-methoxy-3-pyridinyl)-N-[4-(4-methylsulfonylpiperazin-1-yl)cyclohexyl]-9H-pyrido[2,3-b]indol-4-amine;6-(5-methoxy-3-pyridinyl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(1-methylpyrazol-4-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(5-methyl-1H-1,2,4-triazol-3-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrimido[4,5-b]indol-4-amine;N-(4-morpholin-4-ylcyclohexyl)-6-(1H-1,2,4-triazol-5-yl)-9H-pyrimido[4,5-b]indol-4-amine?
The InChIKey is BNBPNJRXSRYBKQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H34N6O3S.C27H31N5O2.C25H30N6O.C23H28N8O.C22H26N8O/c1-37-23-15-20(17-29-18-23)19-3-8-25-24(16-19)27-26(9-10-30-28(27)32-25)31-21-4-6-22(7-5-21)33-11-13-34(14-12-33)38(2,35)36;1-33-22-14-19(16-28-17-22)18-2-7-24-23(15-18)26-25(8-9-29-27(26)31-24)30-20-3-5-21(6-4-20)32-10-12-34-13-11-32;1-30-16-18(15-27-30)17-2-7-22-21(14-17)24-23(8-9-26-25(24)29-22)28-19-3-5-20(6-4-19)31-10-12-32-13-11-31;1-14-26-21(30-29-14)15-2-7-19-18(12-15)20-22(24-13-25-23(20)28-19)27-16-3-5-17(6-4-16)31-8-10-32-11-9-31;1-6-18-17(11-14(1)20-25-13-26-29-20)19-21(23-12-24-22(19)28-18)27-15-2-4-16(5-3-15)30-7-9-31-10-8-30/h3,8-10,15-18,21-22H,4-7,11-14H2,1-2H3,(H2,30,31,32);2,7-9,14-17,20-21H,3-6,10-13H2,1H3,(H2,29,30,31);2,7-9,14-16,19-20H,3-6,10-13H2,1H3,(H2,26,28,29);2,7,12-13,16-17H,3-6,8-11H2,1H3,(H,26,29,30)(H2,24,25,27,28);1,6,11-13,15-16H,2-5,7-10H2,(H,25,26,29)(H2,23,24,27,28).
What are the key properties of 6-(5-methoxy-3-pyridinyl)-N-[4-(4-methylsulfonylpiperazin-1-yl)cyclohexyl]-9H-pyrido[2,3-b]indol-4-amine;6-(5-methoxy-3-pyridinyl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(1-methylpyrazol-4-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(5-methyl-1H-1,2,4-triazol-3-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrimido[4,5-b]indol-4-amine;N-(4-morpholin-4-ylcyclohexyl)-6-(1H-1,2,4-triazol-5-yl)-9H-pyrimido[4,5-b]indol-4-amine?
6-(5-methoxy-3-pyridinyl)-N-[4-(4-methylsulfonylpiperazin-1-yl)cyclohexyl]-9H-pyrido[2,3-b]indol-4-amine;6-(5-methoxy-3-pyridinyl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(1-methylpyrazol-4-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(5-methyl-1H-1,2,4-triazol-3-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrimido[4,5-b]indol-4-amine;N-(4-morpholin-4-ylcyclohexyl)-6-(1H-1,2,4-triazol-5-yl)-9H-pyrimido[4,5-b]indol-4-amine has a molecular weight of 2273.86 g/mol, XLogP of 19.31, 23 rotatable bonds, 12 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for 6-(5-methoxy-3-pyridinyl)-N-[4-(4-methylsulfonylpiperazin-1-yl)cyclohexyl]-9H-pyrido[2,3-b]indol-4-amine;6-(5-methoxy-3-pyridinyl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(1-methylpyrazol-4-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrido[2,3-b]indol-4-amine;6-(5-methyl-1H-1,2,4-triazol-3-yl)-N-(4-morpholin-4-ylcyclohexyl)-9H-pyrimido[4,5-b]indol-4-amine;N-(4-morpholin-4-ylcyclohexyl)-6-(1H-1,2,4-triazol-5-yl)-9H-pyrimido[4,5-b]indol-4-amine is sourced from PubChem (CID 163459145), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).